Skip to content
★ Sign in to follow
Septerna, Inc. logo

Septerna, Inc. Stock: price and insider trades · United States

US·Mcap US$2BHealth Care

No insider purchase over the last 90 days. The latest, by Ezekowitz Alan, was filed 10 Mar 2025.

Insider Decl.
86
Thresholds
n/a
Buy Volume
€87M
19 ops. · all time
Sell Volume
€41M
30 ops. · all time

Septerna, Inc.: what insiders have been doing

Septerna, Inc. is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). 17 insiders have disclosed 56 filings since 17 November 2025.

The flow runs one way only: 29 sales worth €41.4M, from 7 insiders, and no purchase. At €27.5M, the sale published on 14 August 2026 by RA Capital Management, L.P. is the largest of the period (1.5% of market cap).

The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

Compared with its exchange (3,182 companies, median 24 filings), a count of 56 filings is above the norm. The full history, which starts in 2024, counts 19 purchases against 30 sales. The 10-K for the year ended 31 December 2025 shows 46.0 m USD of revenue and -48.9 m USD of net income.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Drägerwerk AG & Co. KGaA. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Who traded when

BuySale
Alan Ezekowitz4 buys7 sales
Elizabeth Bhatt9 sales
Jeffrey Finer3 buys5 sales
Labrucherie Gil M5 buys
Daniel D. Long4 sales
Third Rock Ventures VI, L.P.3 buys

+3 other insiders

Since the insiders bought

  • Filed 10 Mar 2025 · 617 days ago · €86k
    +293.9%
    Entry US$6.68 · Close at T+365 US$26.31
  • Filed 27 Feb 2025 · 628 days ago · €21k
    +342.7%
    Entry US$6.47 · Close at T+365 US$28.64
  • Filed 27 Feb 2025 · 628 days ago · €22k
    +342.7%
    Entry US$6.47 · Close at T+365 US$28.64

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate Septerna, Inc. Strong Buy (bullish), based on 9 analysts. Average price target: US$59.22.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$41.67
Analyst consensus
9 analysts
Strong buy
US$48.00Target US$59.22(+42%)US$65.00
Income statement
RevenueUS$46M
EBITDA-US$79.2M-172% margin
Net income-US$48.9M-61.3% margin
Valuation
PER (forward)-29.2x
P/Book4.6x
Beta2.20
Balance sheet & cash
Market capUS$2B
Total debtUS$23.6M
Free Cash FlowUS$109.7M
Debt / Equity5%
Profitability & ownership
ROE-14.4%
ROA-7.5%
% insiders3.2%
% institutions100.8%
Last declaration on 16 November 2026

T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.

Declarations86 total
  • ●
    Related company / holdingExecutives
    2M USD0Source
    40,000 shares@ US$42.60CommonSEC144:0001950047-26-011182
  • ◇
    Chief Executive OfficerExecutives
    51,060 USD29SEC
    18,500 shares@ US$2.760.0025% mcap4.6% of flowCommon StockSEC:0001193125-26-464072:0
  • ▼
    Chief Executive OfficerExecutives
    235,697 USD48SEC
    5,600 shares@ US$42.08880.012% mcap21.1% of flowCommon StockSEC:0001193125-26-464072:1
  • ▼
    Chief Executive OfficerExecutives
    228,408 USD47SEC
    5,300 shares@ US$43.09590.011% mcap20.5% of flowCommon StockSEC:0001193125-26-464072:2
  • ▼
    Chief Executive OfficerExecutives
    123,833 USD45SEC
    2,800 shares@ US$44.22610.0061% mcap11.1% of flowCommon StockSEC:0001193125-26-464072:3
  • ▼
    Chief Executive OfficerExecutives
    127,812 USD45SEC
    2,823 shares@ US$45.27510.0063% mcap11.5% of flowCommon StockSEC:0001193125-26-464072:4
  • ▼
    Chief Executive OfficerExecutives
    91,264 USD45SEC
    1,977 shares@ US$46.16310.0045% mcap8.2% of flowCommon StockSEC:0001193125-26-464072:5
  • ▼
    DirectorExecutives
    319,229 USD33SEC
    6,939 shares@ US$46.0050.014% mcap7.0% of flowCommon StockSEC:0001193125-26-461248:0
  • ▼
    DirectorExecutives
    620,600 USD34SEC
    13,201 shares@ US$47.01160.027% mcap13.6% of flowCommon StockSEC:0001193125-26-461248:1
  • ▼
    DirectorExecutives
    1M USD37SEC
    22,865 shares@ US$47.77990.047% mcap23.9% of flowCommon StockSEC:0001193125-26-461248:2
  • ▼
    DirectorExecutives
    2M USD39SEC
    31,572 shares@ US$48.70020.066% mcap33.7% of flowCommon StockSEC:0001193125-26-461248:3
  • ▼
    DirectorExecutives
    207,274 USD31SEC
    4,175 shares@ US$49.64650.0089% mcap4.5% of flowCommon StockSEC:0001193125-26-461248:4
  • ▼
    DirectorExecutives
    102,456 USD30SEC
    2,013 shares@ US$50.8970.0044% mcap2.2% of flowCommon StockSEC:0001193125-26-461248:5
  • ▼
    DirectorExecutives
    54,755 USD30SEC
    1,055 shares@ US$51.900.0023% mcap1.2% of flowCommon StockSEC:0001193125-26-461248:6
  • ●
    DirectorExecutives
    5M USD34Source
    100,000 shares@ US$52.340.22% mcap100.0% of flowCommonSEC144:0001950047-26-010978
  • ●
    Director, OfficerExecutives
    3M USD33Source
    66,000 shares@ US$48.560.14% mcap100.0% of flowCommonSEC144:0001950047-26-011038
  • ●
    Related company / holdingExecutives
    15M USD31Source
    306,645 shares@ US$48.560.64% mcap100.0% of flowCommon StockSEC144:0001628280-26-073519
  • ◇
    President and COOExecutives
    27,240 USD18SEC
    4,000 shares@ US$6.810.0016% mcap1.6% of flowCommon StockSEC:0001193125-26-425485:0
  • ▼
    President and COOExecutives
    40,337 USD18SEC
    1,094 shares@ US$36.87150.0024% mcap2.4% of flowCommon StockSEC:0001193125-26-425485:1
  • ▼
    President and COOExecutives
    109,307 USD19SEC
    2,906 shares@ US$37.61420.0065% mcap6.5% of flowCommon StockSEC:0001193125-26-425485:2
  • ●
    OfficerExecutives
    391,339 USD24Source
    10,001 shares@ US$39.130.021% mcap30.4% of flowCommonSEC144:0001950047-26-009973
  • ●
    OfficerExecutives
    492,725 USD27Source
    12,592 shares@ US$39.130.027% mcap63.7% of flowCommonSEC144:0001950047-26-009949
  • ◇
    SVP, Drug DiscoveryExecutives
    9,199 USD18SEC
    3,333 shares@ US$2.760.0005% mcap2.8% of flowCommon StockSEC:0001193125-26-382267:0
  • ▼
    SVP, Drug DiscoveryExecutives
    126,078 USD40SEC
    3,333 shares@ US$37.82710.0063% mcap38.9% of flowCommon StockSEC:0001193125-26-382267:1
  • ▼
    Related company / holdingExecutives
    32M USD52SEC
    746,500 shares@ US$42.501.54% mcap28.3% of flowCommon StockSEC:0001231919-26-000938:0

25 of 86 declarations

About Septerna, Inc.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations

The weekly insider digest, free

One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.